This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Paragon Therapeutics, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jacob Cole Milligan: Innovator in Binding Proteins
Introduction
Jacob Cole Milligan is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of binding proteins. With a total of 2 patents, Milligan's work is paving the way for advancements in therapeutic applications.
Latest Patents
Milligan's latest patents include "IL-17 BINDING PROTEINS, COMPOSITIONS, AND METHODS OF USE THEREOF" and "α4β7 integrin binding proteins and methods of use." These patents provide innovative solutions by introducing α4β7 binding proteins, such as antibodies that bind α4β7, along with methods for their application in various medical contexts.
Career Highlights
Currently, Jacob Cole Milligan is associated with Paragon Therapeutics, Inc., where he continues to push the boundaries of research and development in his field. His work is instrumental in creating new therapeutic options that could benefit patients with specific medical conditions.
Collaborations
Milligan collaborates with talented professionals in his field, including Hussam Hisham Shaheen and Luis Antonio Rodriguez-Carnero. These collaborations enhance the innovative potential of his projects and contribute to the overall success of their research endeavors.
Conclusion
Jacob Cole Milligan is a prominent figure in the biotechnology sector, with a focus on binding proteins that hold promise for future medical applications. His contributions through patents and collaborations reflect his commitment to advancing science and improving healthcare solutions.